Our Company
       Peptides        Janoshik COA
You are here: Home » Research Articles » Peptide Research » Bronchogen: A Guardian of Respiratory Health

Bronchogen: A Guardian of Respiratory Health

network_duotone By Cocer Peptides     network_duotone 1 month ago


ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.




Introduction


Among numerous studies on maintaining respiratory health, Bronchogen has demonstrated its efficacy and potential application value in the field of respiratory health. This article will explore the positive effects of Bronchogen on respiratory health and its application prospects based on existing research.

1

Figure 1 Chemical structure of Bronchogen.





The Effect of Bronchogen on DNA Stability


1. The Potential Link Between DNA Stability and Respiratory Health

The normal function of cells depends on the stable structure of DNA. In the respiratory tract, various environmental factors such as pollutants and pathogens may damage cellular DNA, thereby affecting the normal physiological functions of respiratory cells and leading to a series of respiratory diseases. Maintaining DNA stability is crucial for sustaining the normal metabolic, proliferative, and immune regulatory functions of respiratory cells.


2. Bronchogen as a DNA Stabilizer

At different concentrations, Bronchogen can influence the thermodynamic parameters of DNA. When analyzing DNA using differential scanning microcalorimetry, it was found that Bronchogen can act as a DNA stabilizing agent. When Bronchogen interacts with DNA from bovine thymus and mouse liver, within a narrow r value range (r is the molar ratio of Bronchogen to DNA base pairs, 0.01–0.055), it can increase the DNA denaturation temperature by 3.1°C. This indicates that Bronchogen enhances DNA stability, reduces the risk of DNA damage caused by external factors, and thereby helps maintain normal genetic information transmission and cellular function in respiratory cells.


3. Binding Characteristics and Stability Mechanism

Further studies indicate that Bronchogen is not an adenine-thymine-specific or guanine-cytosine-specific ligand. Its binding type is considered strong and random, and it binds to both strands of DNA (primarily to nitrogenous bases). Within the range of r values from 0.01 to 1.0, the melting enthalpy (ΔH(melt)) of the complex remains constant, further illustrating Bronchogen's unique mechanism of action in stabilizing DNA and providing a strong theoretical basis for its role in maintaining genomic stability in respiratory cells.





Potential Applications of Bronchogen in the Treatment of Respiratory Diseases


1. Disease Prevention Based on DNA Stabilization

Since Bronchogen can stabilize DNA structure, it plays a role in preventing certain respiratory diseases caused by DNA damage. Populations exposed to long-term air pollution are at increased risk of respiratory diseases such as lung cancer and chronic obstructive pulmonary disease (COPD) due to DNA damage in respiratory cells. Bronchogen may reduce this risk by enhancing DNA stability, offering a potential preventive strategy for such populations.


2. Adjuvant Therapy for Respiratory Inflammation

During respiratory inflammation, inflammatory mediators released by inflammatory cells may damage the DNA of respiratory cells. Bronchogen's DNA-stabilizing properties may mitigate such damage to some extent, aiding in the repair and functional recovery of damaged cells. Maintaining normal genetic information transmission in cells may also have a positive effect on regulating the expression of genes related to inflammatory responses, thereby assisting in the treatment of respiratory inflammation.





Conclusion


Although current research on Bronchogen in the field of respiratory health is still in its early stages, existing findings demonstrate its potential. From its impact on DNA stability to its application in the prevention and treatment of respiratory diseases, Bronchogen opens up new directions for respiratory health research.





Source


[1] Monaselidze J R, Khavinson V, Gorgoshidze M Z, et al. Effect of the peptide bronchogen (Ala-Asp-Glu-Leu) on DNA thermostability[J]. Bulletin of Experimental Biology and Medicine, 2011,150(3):375-377.DOI:10.1007/s10517-011-1146-x.


Product available for research use only:

2

 Contact Us Now for A Quote!
Cocer Peptides‌™‌ is a source supplier you can always trust.

QUICK LINKS

CONTACT US
  WhatsApp
+852 6904 8891
 
 
  Signal
+852 6904 8891
  Telegram
@CocerService
Telegram Group:
https://t.me/+ritHPUAhhbA0MThh
  Email
  Shipping Days
Monday-Saturday /Except Sunday
Orders placed and paid after 12 PM PST are shipped the following business day
Disclaimer: All materials offered by Cocer Peptides are supplied exclusively for legitimate laboratory research, analytical investigation, and in vitro experimental use. They are not offered, labeled, represented, or supplied for human or veterinary administration, consumption, injection, implantation, diagnostic use, therapeutic use, disease prevention, treatment, mitigation, or any other clinical application. Products sold through this website are research materials and are not represented as FDA-approved drug products, medicines, dietary supplements, foods, cosmetics, medical devices, or veterinary products. Cocer Peptides does not provide medical, prescribing, dosing, reconstitution, administration, or clinical-use instructions. Product descriptions, technical information, research articles, references to published scientific literature, and links to third-party materials are provided solely for scientific and educational reference and must not be interpreted as medical advice, treatment recommendations, or evidence of approval for human or animal use. Cocer Peptides does not operate as a pharmacy, does not compound drugs pursuant to patient-specific prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act, and is not registered or represented as an outsourcing facility under Section 503B. Purchasers are responsible for ensuring that all materials are acquired, stored, handled, and used only by appropriately qualified personnel in suitable laboratory environments and in accordance with applicable laws, institutional requirements, and safety procedures. As a condition of purchase, the purchaser represents that the materials will not be used in or administered to humans or animals and will not be relabeled, marketed, transferred, or resold for pharmaceutical, therapeutic, diagnostic, clinical, or veterinary purposes. Cocer Peptides reserves the right to refuse, cancel, restrict, or request additional verification for any order where the intended use, purchaser qualifications, destination, or other circumstances are inconsistent with these research-use requirements or applicable law. Additional conditions governing purchase, handling, shipping, liability, and permitted use are set forth in the applicable Terms and Conditions.
Copyright © 2025-2026 Cocer Peptides Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy